Originally posted by lawrence1967
I've been quiet because shorters were making a mozza selling each time I predicted a rise in price. The AGM will be our time to believe again in the transformative power of gene silencing. The management have been under-promising for good reason. Multiple value-creating developments and announcements are lined up to push the share price up to a dollar and keep it there. BB-501, BB-401, sheep trial data, 5 new clinical targets with Axovant. Good luck all holders.
No, you were quiet because you had your embarrassed
@$$ handed to you for making claims that were not based on fact, not provable, and had been repeatedly reminded not to... which is also why the moderators addressed it.
No one on this board is hoping for bad sheep data. No one is hoping for management to fail. But shareholders have the right, and dare say duty, to hold management accountable and expect answers when their investment is not bearing fruit as stated in prior meetings, AKA “shareholder value”.
The issue many many of us have with you Lawrence is that you value your opinion too much, and even raise it to the level of hard and fast truth, despite multiple times where what you say not only doesn’t happen, but does the reverse (Sp retrace).
We wait for news and data. In the meantime, we hold management accountable and ask questions. Anything else, is heresay... especially from you.
